BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9607112)

  • 1. A new approach to gene therapy.
    Zhang Z; Eriksson M; Blombäck M; Anvret M
    Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S39-42. PubMed ID: 9607112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah M; Vandendriessche T
    Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences.
    Chuah MK; Vandendriessche T
    Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for hemophilia: clinical trials and technical tribulations.
    Viiala NO; Larsen SR; Rasko JE
    Semin Thromb Hemost; 2009 Feb; 35(1):81-92. PubMed ID: 19308896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer as an approach to treating hemophilia.
    High KA
    Semin Thromb Hemost; 2003 Feb; 29(1):107-20. PubMed ID: 12640573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy in hemophilia: clinical trials update.
    White GC
    Thromb Haemost; 2001 Jul; 86(1):172-7. PubMed ID: 11487005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy progress and prospects: gene therapy for the hemophilias.
    Walsh CE
    Gene Ther; 2003 Jun; 10(12):999-1003. PubMed ID: 12776156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical gene therapy for haemophilia.
    Chuah MK; Collen D; Vandendriessche T
    Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for hemophilia.
    Ponder KP
    Curr Opin Hematol; 2006 Sep; 13(5):301-7. PubMed ID: 16888433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for hemophilia.
    Chuah MK; Collen D; VandenDriessche T
    J Gene Med; 2001; 3(1):3-20. PubMed ID: 11269333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted gene repair in mammalian cells using chimeric RNA/DNA oligonucleotides and modified single-stranded vectors.
    Parekh-Olmedo H; Czymmek K; Kmiec EB
    Sci STKE; 2001 Mar; 2001(73):pl1. PubMed ID: 11752645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy.
    Youjin S; Jun Y
    Biotechnol Lett; 2009 Mar; 31(3):321-8. PubMed ID: 18979215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical and clinical progress in hemophilia gene therapy.
    Mátrai J; Chuah MK; VandenDriessche T
    Curr Opin Hematol; 2010 Sep; 17(5):387-92. PubMed ID: 20657281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor IX gene therapy for hemophilia.
    Fewell JG
    Methods Mol Biol; 2008; 423():375-82. PubMed ID: 18370215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.
    Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA
    Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation.
    Herzog RW; Mount JD; Arruda VR; High KA; Lothrop CD
    Mol Ther; 2001 Sep; 4(3):192-200. PubMed ID: 11545609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gene therapy for hemophilia: feasible in principle but not yet clinically applicable].
    van der Eb MM; Schagen FH; van Ormondt H; Hoeben RC
    Ned Tijdschr Geneeskd; 1998 Apr; 142(15):840-4. PubMed ID: 9623157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
    Liu L; Mah C; Fletcher BS
    Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.